226 related articles for article (PubMed ID: 31156362)
1.
Song YN; Li JQ; Tan CC; Wang HF; Tan MS; Cao XP; Yu JT; Tan L;
Front Neurosci; 2019; 13():455. PubMed ID: 31156362
[TBL] [Abstract][Full Text] [Related]
2. Associations Between TREML2 Gene Variants and Alzheimer's Disease: Biomarkers, Neuroimage, and Cognition.
Li JQ; Zhong XL; Song JH; Chi S; Xie AM; Tan L; Yu JT;
J Alzheimers Dis; 2023; 96(4):1555-1563. PubMed ID: 37980675
[TBL] [Abstract][Full Text] [Related]
3. Influence of plasma matrix metalloproteinase levels on longitudinal changes in Alzheimer's disease (AD) biomarkers and cognitive function in patients with mild cognitive impairment due to AD registered in the Alzheimer's Disease Neuroimaging Initiative database.
Abe K; Chiba Y; Hattori S; Yoshimi A; Asami T; Katsuse O; Suda A; Hishimoto A;
J Neurol Sci; 2020 Sep; 416():116989. PubMed ID: 32603972
[TBL] [Abstract][Full Text] [Related]
4. Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.
Ben Bouallègue F; Mariano-Goulart D; Payoux P;
Alzheimers Res Ther; 2017 Apr; 9(1):32. PubMed ID: 28441967
[TBL] [Abstract][Full Text] [Related]
5. A TREML2 missense variant influences specific hippocampal subfield volumes in cognitively normal elderly subjects.
Wang SY; Xue X; Duan R; Gong PY; E Y; Jiang T; Zhang YD;
Brain Behav; 2020 Apr; 10(4):e01573. PubMed ID: 32073739
[TBL] [Abstract][Full Text] [Related]
6. A Candidate Regulatory Variant at the
Tian ML; Ni XN; Li JQ; Tan CC; Cao XP; Tan L;
Front Neurosci; 2019; 13():742. PubMed ID: 31379492
[No Abstract] [Full Text] [Related]
7. Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer's disease.
Zhang H; Ng KP; Therriault J; Kang MS; Pascoal TA; Rosa-Neto P; Gauthier S;
Transl Neurodegener; 2018; 7():23. PubMed ID: 30311914
[TBL] [Abstract][Full Text] [Related]
8. Identification of prognostic factors to predict cognitive decline of patients with early Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative study.
Yagi T; Kanekiyo M; Ito J; Ihara R; Suzuki K; Iwata A; Iwatsubo T; Aoshima K; ;
Alzheimers Dement (N Y); 2019; 5():364-373. PubMed ID: 31440579
[TBL] [Abstract][Full Text] [Related]
9. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
[TBL] [Abstract][Full Text] [Related]
10. Temporal Ordering of Inflammatory Analytes sTNFR2 and sTREM2 in Relation to Alzheimer's Disease Biomarkers and Clinical Outcomes.
Pillai JA; Khrestian M; Bena J; Leverenz JB; Bekris LM
Front Aging Neurosci; 2021; 13():676744. PubMed ID: 34276339
[TBL] [Abstract][Full Text] [Related]
11. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.
Burnham SC; Coloma PM; Li QX; Collins S; Savage G; Laws S; Doecke J; Maruff P; Martins RN; Ames D; Rowe CC; Masters CL; Villemagne VL
J Prev Alzheimers Dis; 2019; 6(4):248-255. PubMed ID: 31686097
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal Exposure-Response Modeling of Multiple Indicators of Alzheimer's Disease Progression.
Polhamus DG; Dolton MJ; Rogers JA; Honigberg L; Jin JY; Quartino A
J Prev Alzheimers Dis; 2023; 10(2):212-222. PubMed ID: 36946448
[TBL] [Abstract][Full Text] [Related]
13. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
[TBL] [Abstract][Full Text] [Related]
14. The Associations of Cerebrospinal Fluid ApoE and Biomarkers of Alzheimer's Disease: Exploring Interactions With Sex.
Liu Y; Song JH; Xu W; Hou XH; Li JQ; Yu JT; Tan L; Chi S;
Front Neurosci; 2021; 15():633576. PubMed ID: 33746700
[TBL] [Abstract][Full Text] [Related]
15. Does serum uric acid act as a modulator of cerebrospinal fluid Alzheimer's disease biomarker related cognitive decline?
Ye BS; Lee WW; Ham JH; Lee JJ; Lee PH; Sohn YH;
Eur J Neurol; 2016 May; 23(5):948-57. PubMed ID: 26917248
[TBL] [Abstract][Full Text] [Related]
16. Erlangen Score Predicts Cognitive and Neuroimaging Progression in Mild Cognitive Impairment Stage of Alzheimer's Disease.
Skillbäck T; Kornhuber J; Blennow K; Zetterberg H; Lewczuk P;
J Alzheimers Dis; 2019; 69(2):551-559. PubMed ID: 31104027
[TBL] [Abstract][Full Text] [Related]
17. Low levels of cerebrospinal fluid complement 3 and factor H predict faster cognitive decline in mild cognitive impairment.
Toledo JB; Korff A; Shaw LM; Trojanowski JQ; Zhang J
Alzheimers Res Ther; 2014; 6(3):36. PubMed ID: 25478014
[TBL] [Abstract][Full Text] [Related]
18. Associations of White Matter Hyperintensities with Cognitive Decline: A Longitudinal Study.
Wang YL; Chen W; Cai WJ; Hu H; Xu W; Wang ZT; Cao XP; Tan L; Yu JT;
J Alzheimers Dis; 2020; 73(2):759-768. PubMed ID: 31839612
[TBL] [Abstract][Full Text] [Related]
19. Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI).
Crane PK; Carle A; Gibbons LE; Insel P; Mackin RS; Gross A; Jones RN; Mukherjee S; Curtis SM; Harvey D; Weiner M; Mungas D;
Brain Imaging Behav; 2012 Dec; 6(4):502-16. PubMed ID: 22782295
[TBL] [Abstract][Full Text] [Related]
20. A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment.
Wang H; Stewart T; Toledo JB; Ginghina C; Tang L; Atik A; Aro P; Shaw LM; Trojanowski JQ; Galasko DR; Edland S; Jensen PH; Shi M; Zhang J;
J Alzheimers Dis; 2018; 61(4):1541-1553. PubMed ID: 29376878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
